Acadia to hold Settlement Hearing for Derivative Lawsuit
Acadia Pharmaceuticals is notifying stockholders of a proposed settlement for a 2026 stockholder derivative lawsuit and related demands, with a scheduled 2027 court hearing.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day